Based on our experience and case examples presented - objective cough frequency data has great potential to be a part of remote patient monitoring, smoking cessation and medication adherence, and complement PROs.

Latest in Publications

View All

PublicationsAbstracts

A Prospective Decentralized Pilot Study Assessing a Digital Therapeutic Feature Inside CoughPro: For Adults with RCC/UCC

Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.

4 December 2025

PublicationsPeer-reviewed

The value of continuous cough monitoring: a narrative review

This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.

30 November 2025

PublicationsAbstracts

Azithromycin and Oesophageal Motility in Chronic Respiratory Disease: A Feasibility Trial

Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.

18 November 2025

PublicationsAbstracts

Azithromycin and continuous cough monitoring: an open-label trial

Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.

18 November 2025

Dive into the science. Explore our publications.

READ MORE